Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

Simone H. J. van den Elsen; Onno W. Akkerman; Erwin M. Jongedijk; Mireille Wessels; Samiksha Ghimire; Tjip S. van der Werf; Daan J. Touw; Mathieu S. Bolhuis; Jan-Willem C. Alffenaar

doi:10.1183/13993003.01903-2019

Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

Simone H. J. van den Elsen, Onno W. Akkerman, Erwin M. Jongedijk, Mireille Wessels, Samiksha Ghimire, Tjip S. van der Werf, Daan J. Touw, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

16 Citations (Scopus)

163 Downloads (Pure)

Original language	English
Article number	1901903
Number of pages	4
Journal	European Respiratory Journal
Volume	55
Issue number	5
Early online date	24-Jan-2020
DOIs	https://doi.org/10.1183/13993003.01903-2019
Publication status	Published - 1-May-2020

Keywords

TUBERCULOSIS
FLUID
TB

Access to Document

10.1183/13993003.01903-2019

Therapeutic drug monitoring using saliva as matrix_ an opportunity for linezolid, but challenge for moxifloxacinFinal author's version, 405 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

van den Elsen, S. H. J., Akkerman, O. W., Jongedijk, E. M., Wessels, M., Ghimire, S., van der Werf, T. S., Touw, D. J., Bolhuis, M. S., & Alffenaar, J.-W. C. (2020). Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin. European Respiratory Journal, 55(5), Article 1901903. https://doi.org/10.1183/13993003.01903-2019

@article{eba1278514c3462582f2a1caeb95bb0c,

title = "Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin",

keywords = "TUBERCULOSIS, FLUID, TB",

author = "{van den Elsen}, {Simone H. J.} and Akkerman, {Onno W.} and Jongedijk, {Erwin M.} and Mireille Wessels and Samiksha Ghimire and {van der Werf}, {Tjip S.} and Touw, {Daan J.} and Bolhuis, {Mathieu S.} and Alffenaar, {Jan-Willem C.}",

year = "2020",

month = may,

day = "1",

doi = "10.1183/13993003.01903-2019",

language = "English",

volume = "55",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",

number = "5",

}

TY - JOUR

T1 - Therapeutic drug monitoring using saliva as matrix

T2 - an opportunity for linezolid, but challenge for moxifloxacin

AU - van den Elsen, Simone H. J.

AU - Akkerman, Onno W.

AU - Jongedijk, Erwin M.

AU - Wessels, Mireille

AU - Ghimire, Samiksha

AU - van der Werf, Tjip S.

AU - Touw, Daan J.

AU - Bolhuis, Mathieu S.

AU - Alffenaar, Jan-Willem C.

PY - 2020/5/1

Y1 - 2020/5/1

KW - TUBERCULOSIS

KW - FLUID

KW - TB

U2 - 10.1183/13993003.01903-2019

DO - 10.1183/13993003.01903-2019

M3 - Letter

C2 - 31980497

SN - 0903-1936

VL - 55

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 5

M1 - 1901903

ER -